Healthcare costs attributable to diabetes in pregnancy: A cost of illness study in Tasmania, Australia.
GDM
Tasmania
cost of illness
data linkage
diabetes in pregnancy
gestational diabetes mellitus
pre‐existing diabetes
Journal
Diabetic medicine : a journal of the British Diabetic Association
ISSN: 1464-5491
Titre abrégé: Diabet Med
Pays: England
ID NLM: 8500858
Informations de publication
Date de publication:
02 Aug 2024
02 Aug 2024
Historique:
revised:
27
06
2024
received:
28
10
2023
accepted:
15
07
2024
medline:
2
8
2024
pubmed:
2
8
2024
entrez:
2
8
2024
Statut:
aheadofprint
Résumé
To estimate the direct costs during the prenatal, delivery and postpartum periods in mothers with diabetes in pregnancy, compared to those without. This study used a population-based dataset from 2004 to 2017, including 57,090 people with diabetes and 114,179 people without diabetes in Tasmania, Australia. Based on diagnostic codes, delivery episodes with gestational diabetes mellitus (GDM) were identified and matched with delivery episodes without diabetes in pregnancy. A group of delivery episodes with pre-existing diabetes was identified for comparison. Hospitalisation, emergency department and pathology costs of these groups were calculated and adjusted to 2020-2021 Australian dollars. There were 2774 delivery episodes with GDM, 2774 delivery episodes without diabetes and 237 delivery episodes with pre-existing diabetes identified. Across the 24-month period, the pre-existing diabetes group required the highest costs, totalling $23,536/person. This was followed by the GDM ($13,210/person), and the no diabetes group ($11,167/person). The incremental costs of GDM over the no diabetes group were $890 (95% CI 635; 1160) in the year preceding delivery; $812 (616; 1031) within the delivery period and $341 (110; 582) in the year following delivery (p < 0.05). Within the year preceding delivery, the incremental costs in the prenatal period were $803 (579; 1058) (p < 0.05). Within the year following delivery, the incremental costs in the postpartum period were $137 (55; 238) (p < 0.05). Our results emphasised the importance of proper management of diabetes in pregnancy in the prenatal and postpartum periods and highlighted the significance of screening and preventative strategies for diabetes in pregnancy.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e15417Informations de copyright
© 2024 The Author(s). Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK.
Références
ElSayed NA, Aleppo G, Aroda VR, et al. 2. Classification and diagnosis of Diabetes: standards of Care in Diabetes—2023. Diabetes Care. 2022;46(Supplement_1):S19‐S40. doi:10.2337/dc23-S002
Baz B, Riveline J‐P, Gautier J‐F. ENDOCRINOLOGY OF PREGNANCY: gestational diabetes mellitus: definition, aetiological and clinical aspects. Eur J Endocrinol. 2016;174(2):R43‐R51. doi:10.1530/eje-15-0378
Dłuski DF, Ruszała M, Rudziński G, Pożarowska K, Brzuszkiewicz K, Leszczyńska‐Gorzelak B. Evolution of gestational Diabetes mellitus across continents in 21st century. Int J Environ Res Public Health. 2022;19(23):15804.
Johns EC, Denison FC, Norman JE, Reynolds RM. Gestational Diabetes mellitus: mechanisms, treatment, and complications. Trends Endocrinol Metab. 2018;29(11):743‐754. doi:10.1016/j.tem.2018.09.004
Billionnet C, Mitanchez D, Weill A, et al. Gestational diabetes and adverse perinatal outcomes from 716,152 births in France in 2012. Diabetologia. 2017;60(4):636‐644. doi:10.1007/s00125-017-4206-6
O'Sullivan EP, Avalos G, O'Reilly M, et al. Atlantic Diabetes in pregnancy (DIP): the prevalence and outcomes of gestational diabetes mellitus using new diagnostic criteria. Diabetologia. 2011;54(7):1670‐1675. doi:10.1007/s00125-011-2150-4
Wendland EM, Torloni MR, Falavigna M, et al. Gestational diabetes and pregnancy outcomes—a systematic review of the World Health Organization (WHO) and the International Association of Diabetes in pregnancy study groups (IADPSG) diagnostic criteria. BMC Pregnancy Childbirth. 2012;12(1):23. doi:10.1186/1471-2393-12-23
Bellamy L, Casas J‐P, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta‐analysis. Lancet. 2009;373(9677):1773‐1779. doi:10.1016/S0140-6736(09)60731-5
Getahun D, Fassett MJ, Jacobsen SJ. Gestational diabetes: risk of recurrence in subsequent pregnancies. Am J Obstet Gynecol. 2010;203(5):467.e1‐467.e6. doi:10.1016/j.ajog.2010.05.032
Mortier I, Blanc J, Tosello B, Gire C, Bretelle F, Carcopino X. Is gestational diabetes an independent risk factor of neonatal severe respiratory distress syndrome after 34 weeks of gestation? A prospective study. Arch Gynecol Obstet. 2017;296:1071‐1077.
Son KH, Lim NK, Lee JW, Cho MC, Park HY. Comparison of maternal morbidity and medical costs during pregnancy and delivery between patients with gestational diabetes and patients with pre‐existing diabetes. Diabet Med. 2015;32(4):477‐486. doi:10.1111/dme.12656
Danyliv A, Gillespie P, O'Neill C, et al. Short‐ and long‐term effects of gestational diabetes mellitus on healthcare cost: a cross‐sectional comparative study in the ATLANTIC DIP cohort. Diabet Med. 2015;32(4):467‐476. doi:10.1111/dme.12678
Fox HK, Callander EJ. Health service use and health system costs associated with diabetes during pregnancy in Australia. Nutr Metab Cardiovasc Dis. 2021;31(5):1427‐1433. doi:10.1016/j.numecd.2021.02.009
Bailey C, Skouteris H, Harrison CL, et al. Cost effectiveness of antenatal lifestyle interventions for preventing gestational diabetes and hypertensive disease in pregnancy. PharmacoEconomics‐Open. 2020;4(3):499‐510.
Lloyd M, Morton J, Teede H, et al. Long‐term cost‐effectiveness of implementing a lifestyle intervention during pregnancy to reduce the incidence of gestational diabetes and type 2 diabetes. Diabetologia. 2023;1‐12:1223‐1234.
Laurie JG, Wilkinson SA, Mcintyre HD, Snoswell C. Gestational diabetes mellitus care re‐imagined–a cost‐minimisation analysis: cost savings from a tertiary hospital, using a novel, digital‐based gestational diabetes management model. Aust N Z J Obstet Gynaecol. 2023;63:709‐713.
Moss JR, Crowther CA, Hiller JE, Willson KJ, Robinson JS. Costs and consequences of treatment for mild gestational diabetes mellitus ‐ evaluation from the ACHOIS randomised trial. BMC Pregnancy Childbirth. 2007;7:27. doi:10.1186/1471-2393-7-27
Dinh NT, de Graaff B, Campbell JA, et al. Risk of hospital admission or emergency department presentation due to diabetes complications: a retrospective cohort study in Tasmania, Australia. Aust Health Rev. 2023;47(3):282‐290.
Dinh NT, de Graaff B, Campbell JA, et al. Costs of major complications in people with and without diabetes in Tasmania, Australia. Aust Health Rev. 2022;46(6):667‐678.
Dinh NT, de Graaff B, Campbell JA, et al. Incremental healthcare expenditure attributable to diabetes mellitus: a cost of illness study in Tasmania, Australia. Diabet Med. 2022;39(6):e14817.
Luccisano SP, Weber HC, Murfet GO, Robertson IK, Prior SJ, Hills AP. An audit of pre‐pregnancy maternal obesity and Diabetes screening in rural regional Tasmania and its impact on pregnancy and neonatal outcomes. Int J Environ Res Public Health. 2021;18(22):12006.
Saunder T, Kitsos A, Radford J, et al. Chronic kidney disease in Tasmania: protocol for a data linkage study. JMIR Res Protoc. 2020;9(9):e20160.
Templeton M, Pieris‐Caldwell I. Gestational diabetes mellitus in Australia, 2005‐06. Australian Institute of Health and Welfare Canberra. 2008.
Australian Bureau of Statistics. 2033.0.55.001—Census of Population and Housing: Socio‐Economic Indexes for Areas (SEIFA), Australia, 2016. 2022. https://www.abs.gov.au/ausstats/abs@.nsf/Lookup/by%20Subject/2033.0.55.001~2016~Main%20Features~IRSAD~20
The Independent Health and Aged Care Pricing Authority (IHACPA). AR‐DRGs. 2023. https://www.ihacpa.gov.au/health‐care/classification/admitted‐acute‐care/ar‐drgs
The Independent Health and Aged Care Pricing Authority (IHACPA). URGs and UDGs. 2023. https://www.ihacpa.gov.au/health‐care/classifications/emergency‐care/urgs‐and‐udgs
The independent health and aged care pricing authority. National Efficient Price Determination. 2023. https://www.ihacpa.gov.au/health‐care/pricing/national‐efficient‐price‐determination
Department of Health, Australian Government. Medicare Benefits Schedule. 2021. http://www.mbsonline.gov.au/internet/mbsonline/publishing.nsf/Content/Downloads‐201201a
Campbell JA, Hensher M, Davies D, et al. Long‐term inpatient hospital utilisation and costs (2007–2008 to 2015–2016) for publicly waitlisted bariatric surgery patients in an Australian public hospital system based on Australia's activity‐based funding model. PharmacoEconomics‐Open. 2019;3(4):599‐618.
Thompson SG, Barber JA. How should cost data in pragmatic randomised trials be analysed? BMJ. 2000;320(7243):1197‐1200. doi:10.1136/bmj.320.7243.1197
Lumley T, Diehr P, Emerson S, Chen L. The importance of the normality assumption in large public health data sets. Annu Rev Public Health. 2002;23(1):151‐169. doi:10.1146/annurev.publhealth.23.100901.140546
Sundararajan V, Henderson T, Perry C, Muggivan A, Quan H, Ghali WA. New ICD‐10 version of the Charlson comorbidity index predicted in‐hospital mortality. J Clin Epidemiol. 2004;57(12):1288‐1294.
Stagg V. CHARLSON: Stata Module to Calculate Charlson Index of Comorbidity. 2017.
Onukwugha E, McRae J, Kravetz A, Varga S, Khairnar R, Mullins CD. Cost‐of‐illness studies: an updated review of current methods. PharmacoEconomics. 2016;34:43‐58.
Ornoy A, Becker M, Weinstein‐Fudim L, Ergaz Z. Diabetes during pregnancy: a maternal disease complicating the course of pregnancy with long‐term deleterious effects on the offspring. A clinical review. Int J Mol Sci. 2021;22(6):2965.
Nankervis A, McIntyre H, Moses R, et al. ADIPS consensus guidelines for the testing and diagnosis of gestational diabetes mellitus in Australia. 2014.
Fadl HE, Östlund I, Magnuson A, Hanson US. Maternal and neonatal outcomes and time trends of gestational diabetes mellitus in Sweden from 1991 to 2003. Diabet Med. 2010;27(4):436‐441.
Damm P, Houshmand‐Oeregaard A, Kelstrup L, Lauenborg J, Mathiesen ER, Clausen TD. Gestational diabetes mellitus and long‐term consequences for mother and offspring: a view from Denmark. Diabetologia. 2016;59:1396‐1399.